5-Hydroxymethylcytosine signatures as diagnostic biomarkers for septic cardiomyopathy
Abstract At present, there are currently no molecular biomarkers for the early diagnosis of sepsis cardiomyopathy (SCM) in clinical practice. This study focuses on an in-depth examination of the DNA hydroxymethylation profiles within plasma extracellular vesicles and explores potential molecular bio...
Saved in:
| Main Authors: | Baixin Zhen, Zhiling Zhao, Hangyu Chen, Wen Li, Lei Zhang, Xi Zhu, Qinggang Ge, Jian Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-02489-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
5-Hydroxymethylcytosine profilings in circulating cell-free DNA as diagnostic biomarkers for DLBCL
by: Hangyu Chen, et al.
Published: (2024-11-01) -
5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation
by: Danjun Song, et al.
Published: (2025-03-01) -
Immunohistochemical detection of 5-hydroxymethylcytosine as a prognostic biomarker in non-WNT/Non-SHH medulloblastomas
by: Han-Guang Zhao, et al.
Published: (2025-05-01) -
Inflammation-related 5-hydroxymethylation signatures as markers for clinical presentations of coronary artery disease
by: Jing Xu, et al.
Published: (2025-06-01) -
Direct and bisulfite-free 5-methylcytosine and 5-hydroxymethylcytosine sequencing at single-cell resolution with scTAPS and scCAPS +
by: Xiufei Chen, et al.
Published: (2025-08-01)